Growth and Investment Procaps recently secured 130 million dollars in equity funding and completed a debt restructuring, positioning itself for expansion and new strategic initiatives. This financial strengthening presents opportunities to offer innovative solutions supporting their growth trajectory.

Market Focus As a leading healthcare and pharmaceutical services provider in LatAm, Procaps operates in a rapidly expanding region with significant demand for healthcare innovations, creating potential for tailored supply chain, logistics, and tech solutions to enhance their service delivery.

Research & Development Procaps is actively involved in clinical trials and pharmaceutical advancements, including collaborations in oncology and hormone therapy. Selling opportunities exist in medical technology, clinical trial management, and specialized medical supplies to support their R&D efforts.

Regulatory Navigation The company has recently experienced delisting from NASDAQ due to reporting delays but continues to pursue approvals and submissions, indicating ongoing regulatory activity. Solutions that streamline compliance or support regulatory processes could be highly valued.

Leadership Shifts Recent changes in governance and executive leadership signal a strategic repositioning, making it an opportune moment to approach with innovative digital tools, consulting services, or corporate governance solutions that align with their new direction.